Germany Ready to Step On The Gas For Medtech But Reimbursement Delays Still Block The Road
After very complex national elections in 2017, Jens Spahn (CDU) emerged from the confusion holding the health portfolio. He is now ready to broach the trickier elements of his role, including finding solutions for the currently lengthy reimbursement delays for innovative medtech, which is a top priority for local manufacturers.
You may also be interested in...
Germany's center-left SPD party will be the junior partner in the new government after 66% of party members voted in favor of another coalition with the center-right Christian Union parties led by Angela Merkela. Jens Spahn, who is in Merkel's party but not in her inner circle, has already been given the health portfolio.
Germany’s eHealth law has had its first reading in the lower house and is on its way into law, with the enthusiastic backing of the health ministry. But users of telehealth applications and the medical devices industry think it does not go far enough or fast enough, as ZVEI* medical engineering managing director Hans-Peter Bursig tells Clinica
Confusion is rife over low UK testing levels to confirm COVID-19 in health care staff and patients, and comparisons with measures taken in similar-sized economies have been unfavorable. Diagnostics manufacturers are not to blame, says the industry.